Literature DB >> 11544280

Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis.

T Chitnis1, N Najafian, C Benou, A D Salama, M J Grusby, M H Sayegh, S J Khoury.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is mediated by myelin-specific CD4(+) T cells secreting Th1 cytokines, while recovery from disease is associated with expression of Th2 cytokines. Investigations into the role of individual cytokines in disease induction have yielded contradictory results. Here we used animals with targeted deletion of the STAT4 or STAT6 genes to determine the role of these signaling molecules in EAE. The STAT4 pathway controls the differentiation of cells into a Th1 phenotype, while the STAT6 pathway controls the differentiation of cells into a Th2 phenotype. We found that mice deficient in STAT4 are resistant to the induction of EAE, with minimal inflammatory infiltrates in the central nervous system. In contrast, STAT6-deficient mice, which have a predominantly Th1 phenotype, experience a more severe clinical course of EAE as compared with wild-type or STAT4 knockout mice. In addition, adoptive transfer studies confirm the regulatory functions of a Th2 environment in vivo. These novel data indicate that STAT4 and STAT6 genes play a critical role in regulating the autoimmune response in EAE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544280      PMCID: PMC209380          DOI: 10.1172/JCI12563

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  61 in total

1.  CD28-independent induction of experimental autoimmune encephalomyelitis.

Authors:  T Chitnis; N Najafian; K A Abdallah; V Dong; H Yagita; M H Sayegh; S J Khoury
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Regulation of alloantigen-mediated T-cell proliferation by endogenous interferon-gamma: implications for long-term allograft acceptance.

Authors:  A T Hassan; Z Dai; B T Konieczny; G H Ring; F K Baddoura; L H Abou-Dahab; A A El-Sayed; F G Lakkis
Journal:  Transplantation       Date:  1999-07-15       Impact factor: 4.939

3.  Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity.

Authors:  M B Powell; D Mitchell; J Lederman; J Buckmeier; S S Zamvil; M Graham; N H Ruddle; L Steinman
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

4.  Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse.

Authors:  T T Duong; J St Louis; J J Gilbert; F D Finkelman; G H Strejan
Journal:  J Neuroimmunol       Date:  1992-02       Impact factor: 3.478

5.  Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein.

Authors:  C Linington; M Bradl; H Lassmann; C Brunner; K Vass
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

6.  Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis.

Authors:  F D Lublin; R L Knobler; B Kalman; M Goldhaber; J Marini; M Perrault; C D'Imperio; J Joseph; S S Alkan; R Korngold
Journal:  Autoimmunity       Date:  1993       Impact factor: 2.815

7.  The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin.

Authors:  G Kaplan; A D Luster; G Hancock; Z A Cohn
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

8.  Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).

Authors:  A D Luster; J V Ravetch
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

9.  Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation.

Authors:  A Mathew; J A MacLean; E DeHaan; A M Tager; F H Green; A D Luster
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307

10.  Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.

Authors:  S J Khoury; W W Hancock; H L Weiner
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  89 in total

1.  Regulatory functions of CD8+CD28- T cells in an autoimmune disease model.

Authors:  Nader Najafian; Tanuja Chitnis; Alan D Salama; Bing Zhu; Christina Benou; Xueli Yuan; Michael R Clarkson; Mohamed H Sayegh; Samia J Khoury
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 2.  Janus-like effects of type I interferon in autoimmune diseases.

Authors:  Robert C Axtell; Chander Raman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 3.  Th17 cells: effector T cells with inflammatory properties.

Authors:  Thomas Korn; Mohamed Oukka; Vijay Kuchroo; Estelle Bettelli
Journal:  Semin Immunol       Date:  2007-11-26       Impact factor: 11.130

4.  T-bet and eomesodermin play critical roles in directing T cell differentiation to Th1 versus Th17.

Authors:  Yu Yang; Jiangnan Xu; Yanyan Niu; Jonathan S Bromberg; Yaozhong Ding
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 5.  Therapeutic modulators of STAT signalling for human diseases.

Authors:  Gabriella Miklossy; Tyvette S Hilliard; James Turkson
Journal:  Nat Rev Drug Discov       Date:  2013-08       Impact factor: 84.694

6.  Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines.

Authors:  Yoshimitsu Doi; Shinji Oki; Tomoko Ozawa; Hirohiko Hohjoh; Sachiko Miyake; Takashi Yamamura
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-11       Impact factor: 11.205

7.  Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease.

Authors:  Eugene Y Chiang; Ganesh A Kolumam; Xin Yu; Michelle Francesco; Sinisa Ivelja; Ivan Peng; Peter Gribling; Jean Shu; Wyne P Lee; Canio J Refino; Mercedesz Balazs; Andres Paler-Martinez; Allen Nguyen; Judy Young; Kai H Barck; Richard A D Carano; Ron Ferrando; Lauri Diehl; Devavani Chatterjea; Jane L Grogan
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

8.  Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.

Authors:  Yudong Liu; Andrew T Holdbrooks; Patrizia De Sarno; Amber L Rowse; Lora L Yanagisawa; Braden C McFarland; Laurie E Harrington; Chander Raman; Steffanie Sabbaj; Etty N Benveniste; Hongwei Qin
Journal:  J Immunol       Date:  2013-12-09       Impact factor: 5.422

9.  Autoimmunity: increasing suspects in the CD4+ T cell lineup.

Authors:  Matthew T Palmer; Casey T Weaver
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

10.  Stat6 signaling suppresses VLA-4 expression by CD8+ T cells and limits their ability to infiltrate tumor lesions in vivo.

Authors:  Kotaro Sasaki; Xi Zhao; Angela D Pardee; Ryo Ueda; Mitsugu Fujita; Sarita Sehra; Mark H Kaplan; Lawrence P Kane; Hideho Okada; Walter J Storkus
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.